Skip to main content

FDx Advisors, Inc.

SEC CIK
0001566601
Latest filing
Aug 4, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by FDx Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of NVO by FDx Advisors, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−6,017−100.0%Sold outHolders
Q4 20256,017$306.0K0.2%+298+5.2%AddedHolders
Q3 20255,719$283.0K0.1%−771−11.9%ReducedHolders
Q2 20256,490$448.0K0.1%−3,802−36.9%ReducedHolders
Q1 202510,292$715.0K0.2%−1,541−13.0%ReducedHolders
Q4 202411,833$1.02M0.3%+1,655+16.3%AddedHolders
Q3 202410,178$1.21M0.3%−458−4.3%ReducedHolders
Q2 202410,636$1.52M0.4%−29,046−73.2%ReducedHolders
Q1 202439,682$5.09M0.8%−19,680−33.2%ReducedHolders
Q4 202359,362$6.14M0.5%+8,870+17.6%AddedHolders
Q3 202350,492$4.59M0.4%−17,028−25.2%ReducedConverted for a 2-for-1 splitHolders
Q2 202333,760$5.46M0.3%+3,026+9.8%AddedHolders
Q1 202330,734$4.16M0.2%00.0%UnchangedHolders
Q4 202230,734$4.16M0.2%−3,889−11.2%ReducedHolders
Q3 202234,623$3.45M0.2%−12,139−26.0%ReducedHolders
Q2 202246,762$5.21M0.2%−15,388−24.8%ReducedHolders
Q1 202262,150$6.90M0.2%+2,691+4.5%AddedHolders
Q4 202159,459$6.66M0.2%+3,478+6.2%AddedHolders
Q3 202155,981$5.38M0.2%+1,984+3.7%AddedHolders
Q2 202153,997$4.52M0.2%+7,060+15.0%AddedHolders
Q1 202146,937$3.16M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.